Voltage: Investigator-initiated clinical trial of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable locally advanced rectal cancer.
Takayuki Yoshino(University of Tsukuba), Masaaki Ito(National Cancer Centre Japan), Yuichiro Tsukada(National Cancer Center Hospital East), Mamoru Uemura(Osaka International Cancer Institute), Takeshi Sasaki(Sapporo Medical University), Hiroyoshi Nishikawa(Immunité et Cancer), Yuji Nishizawa(National Cancer Center Hospital East), Daisuke Kotani(National Cancer Center Hospital East), Yosuke Togashi(Okayama University), Shigenori Homma(Hokkaido University), Hideaki Bando(Aichi Cancer Center), Yoshito Komatsu(Hokkaido University Hospital), Masashi Wakabayashi(Japan Clinical Cancer Research Organization), Akihiro Sato(Yokohama Municipal Citizen's Hospital), Motohiro Kojima(Chiba Cancer Center), Takeshi Kato(Osaka National Hospital), Satoshi Yuki(Hokkaido University Hospital), Shota Fukuoka(National Cancer Research Institute), Naoki Nakamura(St. Marianna University School of Medicine), Koji Inamori(National Cancer Center Hospital East)
Cited by 17
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k